The international NC3Rs Prize, sponsored by GlaxoSmithKline, is awarded to highlight an outstanding original contribution to scientific and technological advances in the 3Rs in medical, biological or veterinary sciences published within the last three years. The prize is part of our commitment to recognise and reward high quality research which has an impact on the use of animals in the life sciences.
The prize consists of a grant of £18k, plus a personal award of £2k. Highly-commended entries receive a £4k grant and £1k personal award.
The 3Rs Prize is now closed.
For further information on the 3Rs Prize, please contact 3Rsprize@nc3rs.org.uk
The 3Rs prize is for a piece of primary research published in a peer-reviewed journal in the last three years and is open to any researcher, in academia or industry. The prize is awarded to the principal investigator, research team leader, or other nominated author. The Prize is open to international groups.
Applications are assessed by a dedicated Panel, which also selects the winner. Selection is based on the quality of the published research and its impact on the 3Rs.
Applications are welcomed from any research establishment, including Higher Education Institutions, Hospital/NHS Trusts, Research Council Establishments, Charity Laboratories and Industry. Establishments outside of the UK are also eligible to apply.
Journal papers that contain primary research that advances or has the potential to advance the 3Rs are eligible. The work must have been published in a peer reviewed journal between 1 September 2012 and 1 September 2015. Papers that are in press by 1 September 2015 will also be considered.
An application form should be completed with the research paper attached. Nominations are welcome from anyone who is familiar with the research paper - e.g. lead or other author, head of department, journal editor or colleagues. The candidate nominated for the prize should normally be the lead author of the paper. In cases where the 3Rs aspects of the work were carried out by another author, the lead author can delegate the nomination. Entries are limited to one per individual or research group.
Guidance on completing the application form is available.
Entries are assessed by the 3Rs prize Selection Panel based on:
- Whether it has advanced an area of research
- Impact on the 3Rs
- How well the 3Rs implications have been disseminated
- Whether the proposal for using the prize grant supports further development of the 3Rs.
|Member name||Institution||Term Ends|
University of Manchester
University of Nottingham
Dr Declan Mulkeen
Medical Resarch Council
Biotechnology and Biological Sciences Research Council
Declarations of interest
Panel members are required to declare any private, professional or commercial interests that might, or that might be perceived to, conflict with the NC3Rs interests.